# ABM Industries Inc: Form 10-Q for the period ended Jan 31, 2022

- Company: [ABM Industries Inc](/companies/abm.md) (CIK 771497)
- Form: 10-Q
- Filed: 2022-03-09
- Accepted by EDGAR: Mar 9, 2022, 14:09 ET
- Period: 2022-01-31
- Accession: 0000771497-22-000004
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/771497/000077149722000004/abm-20220131.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/771497/000077149722000004/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-01-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-11-01 to 2022-01-31 | $1.94bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2021-11-01 to 2022-01-31 | $1.66bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months, 2021-11-01 to 2022-01-31 | $153.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2021-11-01 to 2022-01-31 | $106.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-11-01 to 2022-01-31 | $6.2m | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-11-01 to 2022-01-31 | $24.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-11-01 to 2022-01-31 | $76.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-11-01 to 2022-01-31 | $1.11 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-11-01 to 2022-01-31 | $1.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-11-01 to 2022-01-31 | 68,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2021-11-01 to 2022-01-31 | −$93.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2021-11-01 to 2022-01-31 | $9.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2021-11-01 to 2022-01-31 | $13.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2021-11-01 to 2022-01-31 | $13.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2022-01-31 | $46.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-01-31 | $1.48bn | us-gaap:AssetsCurrent |
| Total assets | at 2022-01-31 | $4.50bn | us-gaap:Assets |
| Current liabilities | at 2022-01-31 | $1.27bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-01-31 | $2.85bn | us-gaap:Liabilities |
| Long-term debt | at 2022-01-31 | $971.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2022-01-31 | $31.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2022-01-31 | $1.66bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 37,752 characters.

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to facilitate an understanding of the results of operations and financial condition of ABM. This MD&A is provided as a supplement to, and should be read in conjunction with, our Financial Statements and our Annual Report on Form 10-K for the year ended October 31, 2021, which has been filed with the SEC. This MD&A contains forward-looking statements about our business, operations, and industry that involve risks and uncertainties, such as statements regarding our plans, objectives, expectations, and intentions. Our future results and financial condition may be materially different from those we currently anticipate. See “Forward-Looking Statements” for more information.

Throughout the MD&A, amounts and percentages may not recalculate due to rounding. Unless otherwise indicated, all information in the MD&A and references to years are based on our fiscal years, which end on October 31.

### Business Overview

ABM is a leading provider of integrated facility solutions, customized by industry, with a mission to **make a difference, every person, every day.**

### COVID-19 Pandemic

COVID-19 has resulted in a worldwide health Pandemic and created unanticipated circumstances and uncertainty, disruption, and significant volatility in the broader economy. The preventative and protective actions that governments have ordered and that our clients have implemented in response to the Pandemic have led to an increased demand for our services, including higher margin work orders and our EnhancedClean services. While overall demand for these services has decreased as Pandemic-related restrictions continue to loosen, we expect that ongoing concerns around COVID-19 variants combined with our **ELEVATE** strategy, described further below, will lead to new and incremental opportunities for our services. However, given the unprecedented and uncertain nature and potential duration of this situation, we cannot reasonably estimate the impact the Pandemic will have on the demand for our services as well as our financial condition, results of operations, or cash flows. Refer to “Consolidated Results of Operations” and “Results of Operations by Segment” for additional information related to the impact of the Pandemic on our financial results.

### ELEVATE Strategy

In December 2021, we announced our multiyear strategic plan called **ELEVATE**. Our new strategy is designed to strengthen our industry leadership position through end-market repositioning and build on our core services, which we expect will drive significant long-term value for our stakeholders.

Over the next four years, we plan to make significant investments totaling $150 – $175 million and implement various measures with the aim to **ELEVATE:**

- the client experience, by serving as a trusted advisor who can provide innovative multiservice solutions and consistent service delivery;
- the team member experience, by investing in workforce management, training, developing the next generation of ABM leaders, and building on our inclusive culture; and
- our use of technology and data to power client and employee experiences with cutting-edge data and analytics, processes, and tools that will fundamentally change how we operate our business.

### Insurance

We review our self-insurance liabilities on a regular basis and adjust our accruals accordingly. Actual claims activity or development may vary from our assumptions and estimates, which may result in material losses or gains. As we obtain additional information that affects the assumptions and estimates used in our reserve liability calculations, we adjust our self-insurance rates and reserves for future periods and, if appropriate, adjust our reserves for claims incurred in prior accounting periods.

During the first quarter of 2022, we performed a comprehensive actuarial review of the majority of our casualty insurance programs to evaluate changes made to claims reserves and claims payment activity for the period of May 1, 2021, through October 31, 2021. The Actuarial Review was comprehensive in nature and was based on loss development patterns, trend assumptions, and underlying expected loss costs during the period analyzed. The Actuarial Review and other actuarial updates performed earlier in the year demonstrated that the changes we have made to our risk management programs continue to positively impact the frequency and severity of claims.

The claims management strategies and programs that we have implemented have resulted in improvements. Furthermore, we continue to adjust our reserves consistent with known fact patterns. Based on the results of the Actuarial Review, we decreased our total reserves related to prior periods for known claims as well as our estimate of the loss amounts associated with IBNR claims by $25.2 million during the three months ended January 31, 2022. The favorable review was primarily driven by improvements in the workers’ compensation program, reflecting reduced claim frequency related to the Pandemic and positive influences of claim closure projects and reserving practices. During the three months ended January 31, 2021, we decreased our total reserves related to prior period claims by $11.4 million. We will continue to assess ongoing developments, which may result in further adjustments to reserves.

### Segment Reporting

Effective November 1, 2021, we reorganized our reportable segments to reflect our M&D industry group replacing our T&M industry group as part of our **ELEVATE** strategy. Our current reportable segments consist of B&I, M&D, Education, Aviation, and Technical Solutions, as further described below. Additionally, we have modified the presentation of segment revenues in that inter-segment revenues are now allocated at the segment level. Our prior period segment data has been reclassified to conform with our fiscal 2022 presentation. These changes had no impact on our previously reported consolidated financial statements.

### REPORTABLE SEGMENTS AND DESCRIPTIONS

B&I, our largest reportable segment, encompasses janitorial, facilities engineering, and parking services for commercial real estate properties, sports and entertainment venues, and traditional hospitals and non-acute healthcare facilities. B&I also provides vehicle maintenance and other services to rental car providers.

M&D provides integrated facility services, engineering, janitorial, and other specialized services in different types of manufacturing, distribution, and data center facilities. Manufacturing facilities include traditional motor vehicles, electric vehicles, batteries, pharmaceuticals, steel, semiconductors, chemicals, and many others. Distribution facilities include e-commerce, cold storage, logistics, general warehousing, and others.

Education delivers janitorial, custodial, landscaping and grounds, facilities engineering, and parking services for public school districts, private schools, colleges, and universities.

Aviation supports airlines and airports with services ranging from parking and janitorial to passenger assistance, catering logistics, air cabin maintenance, and transportation.

Technical Solutions specializes in mechanical and electrical services. These services can also be leveraged for cross-selling across all of our industry groups, both domestically and internationally.

25

### Key Financial Highlights

- Revenues increased by $443.8 million, or 29.7%, during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021, primarily driven by a $307.7 million revenue increase due to the Able Acquisition in the fourth quarter of 2021, the recovery in volume of our business as Pandemic disruptions eased (primarily in Aviation and B&I), and new business within Aviation, M&D, and Technical Solutions. The increase in revenues was partially offset by a decrease in work orders for Pandemic-related demands (primarily in M&D).
- We had a decrease in operating profit of $3.7 million, or 3.4%, during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. This decrease was primarily attributed to:
- increase in technology transformation costs under our **ELEVATE** strategy;
- increase in compensation and related expenses primarily attributable to the addition of overhead related to the Able Acquisition and talent acquisition activities; and
- acquisition and integration costs and amortization of intangibles related to the Able Acquisition.

The decrease was partially offset by:

- increase in the volume in our business due to the Able Acquisition and the easing of Pandemic disruptions and net new business;
- lower self-insurance expense; and
- a $7.7 million gain recognized on the sale of a group of customer contracts related to healthcare technology management services within Technical Solutions.
- Our effective tax rate on income from operations was 24.2% for the three months ended January 31, 2022, as compared to 26.7% for the three months ended January 31, 2021.
- Net cash used in operating activities was $93.6 million during the three months ended January 31, 2022. Typically, our total operating cash flows in the first quarter are lower than in subsequent quarters of the year, primarily due to the timing of certain working capital requirements during the first quarter, which included a $66 million payment for deferred payroll taxes under the CARES Act.
- Dividends of $13.1 million were paid to shareholders and dividends totaling $0.195 per common share were declared during the three months ended January 31, 2022.
- At January 31, 2022, total outstanding borrowings under our Amended Credit Facility were $1.0 billion. At January 31, 2022, we had up to $749.3 million of borrowing capacity.

### Results of Operations

### Three Months Ended January 31, 2022 Compared with the Three Months Ended January 31, 2021

### Consolidated

*(in millions, except per share amounts)*

|  | Three Months Ended January 31, 2022 | 2021 | Increase / (Decrease) |  |
| --- | ---: | ---: | ---: | ---: |
| **Revenues** | $1,936.2 | $1,492.4 | $443.8 | 29.7% |
| Operating expenses | 1,659.6 | 1,249.4 | 410.2 | 32.8% |
| Gross margin | 14.3% | 16.3% | (200) bps |  |
| Selling, general and administrative expenses | 153.1 | 122.6 | 30.5 | 24.9% |
| Amortization of intangible assets | 17.5 | 10.8 | 6.7 | 62.5% |
| **Operating profit** | 106.0 | 109.7 | (3.7) | (3.4)% |
| Income from unconsolidated affiliates | 0.5 | 0.6 | (0.1) | (21.4)% |
| Interest expense | (6.2) | (8.5) | 2.3 | 26.4% |
| Income before income taxes | 100.3 | 101.9 | (1.6) | (1.6)% |
| Income tax provision | (24.3) | (27.2) | 2.9 | 10.8% |
| **Net income** | 76.0 | 74.6 | 1.4 | 1.8% |
| Other comprehensive income (loss) |  |  |  |  |
| Interest rate swaps | 0.6 | 1.2 | (0.6) | (51.1)% |
| Foreign currency translation and other | (2.4) | 4.0 | (6.4) | NM\* |
| Income tax provision | (0.2) | (0.4) | 0.2 | 50.5% |
| **Comprehensive income** | $74.0 | $79.5 | $(5.5) | (7.0)% |

\*Not meaningful

### Revenues

Revenues increased by $443.8 million, or 29.7%, during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. This increase was primarily driven by a $307.7 million revenue increase due to the Able Acquisition in the fourth quarter of 2021, the recovery in volume of our business as Pandemic disruptions eased (primarily in Aviation and B&I), and new business within Aviation, M&D, and Technical Solutions. The increase in revenues was partially offset by a decrease in work orders for Pandemic-related demands (primarily in M&D).

### Operating Expenses

Operating expenses increased by $410.2 million, or 32.8%, during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. Gross margin decreased by 200 bps to 14.3% in the three months ended January 31, 2022, from 16.3% in the three months ended January 31, 2021. The decrease in gross margin was primarily driven by the changes in contract mix due to decrease in cleaning services for Pandemic-related demands (primarily in B&I and M&D), which have higher margins, and the Able Acquisition. In addition, gross margin was also negatively impacted by an increase in direct labor and related costs (primarily in Education) due to the recovery in headcount as schools expanded capacity for in-person learning. The decrease was partially offset by lower self-insurance expense related to the prior periods, driven by improvement in the workers’ compensation program, reflecting reduced claim frequency related to the Pandemic and positive influences of claim closure projects and reserving practices.

### Selling, General and Administrative Expenses

Selling, general and administrative expenses increased by $30.5 million during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. The increase in selling, general and administrative expenses was primarily attributable to:

- a $19.5 million increase in compensation and related expenses primarily attributable to the addition of overhead related to the Able Acquisition and talent acquisition activities;
- a $11.5 million increase in certain technology projects attributable to discrete transformational costs under our **ELEVATE** strategy for developing the new enterprise resource planning system, client facing technology, workforce management tools, and data analytic; and
- an $8.3 million increase in acquisition and integration costs attributable to the Able Acquisition.

This increase was partially offset by:

- a $7.7 million gain recognized on the sale of a group of customer contracts related to healthcare technology management services within Technical Solutions; and
- a $2.1 million decrease in bad debt expense.

### Amortization of Intangible Assets

Amortization of intangible assets increased by $6.7 million, or 62.5%, during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. The increase was primarily due to the amortization of intangibles acquired as part of the Able Acquisition.

### Interest Expense

Interest expense decreased by $2.3 million, or 26.4%, during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021, primarily due to lower relative interest rates in the current year as the result of amending our credit facility in the third quarter of fiscal year 2021.

### Income Taxes from Operations

Our effective tax rates from income on operations for the three months ended January 31, 2022, and January 31, 2021, were 24.2% and 26.7%, respectively, resulting in tax provisions of $24.3 million and $27.2 million, respectively.

Our effective tax rate for the three months ended January 31, 2022, was impacted by a $3.5 million benefit from change in tax reserves. Our effective tax rate for the three months ended January 31, 2021, was not impacted by any significant discrete items The difference between the effective tax rate and statutory rate is primarily related to tax credits and reserves.

### Interest Rate Swaps

During the three months ended January 31, 2022, interest rate swaps decreased by $0.6 million, or 51.1%, as compared to the three months ended January 31, 2021, primarily due to underlying changes in the fair value of our interest rate swaps.

### Foreign Currency Translation

We had a foreign currency translation loss of $2.4 million during the three months ended January 31, 2022, as compared to a foreign currency translation gain of $4.0 million during the three months ended January 31, 2021. This change was due to fluctuations in the exchange rate between the U.S. Dollar (“USD”) and the British pound sterling (“GBP”). Future gains and losses on foreign currency translation will be dependent upon changes in the relative value of foreign currencies to the USD and the extent of our foreign assets and liabilities.

### Segment Information

### Financial Information for Each Reportable Segment

*(in millions)*

| Revenues | Three Months Ended January 31, 2022 | 2021 | Increase / (Decrease) |  |
| --- | ---: | ---: | ---: | ---: |
| Business & Industry | $1,029.5 | $690.1 | $339.4 | 49.2% |
| Manufacturing & Distribution | 359.1 | 340.8 | 18.3 | 5.4% |
| Education | 205.7 | 208.0 | (2.3) | (1.1)% |
| Aviation | 200.3 | 140.9 | 59.4 | 42.1% |
| Technical Solutions | 141.8 | 112.6 | 29.2 | 25.9% |
|  | $1,936.2 | $1,492.4 | $443.8 | 29.7% |
| **Operating profit** |  |  |  |  |
| Business & Industry | $83.3 | $72.7 | $10.6 | 14.6% |
| Operating profit margin | 8.1% | 10.5% | (244) bps |  |
| Manufacturing & Distribution | 40.6 | 39.7 | 0.9 | 2.3% |
| Operating profit margin | 11.3% | 11.7% | (34) bps |  |
| Education | 12.6 | 21.7 | (9.1) | (41.7)% |
| Operating profit margin | 6.1% | 10.4% | (428) bps |  |
| Aviation | 8.9 | 3.1 | 5.8 | NM\* |
| Operating profit margin | 4.4% | 2.2% | 223 bps |  |
| Technical Solutions | 16.9 | 6.0 | 10.9 | NM\* |
| Operating profit margin | 11.9% | 5.3% | 656 bps |  |
| Government Services | (0.1) | (0.1) | — | 45.2% |
| Operating margin | NM\* | NM\* | NM\* |  |
| Corporate | (55.8) | (32.6) | (23.2) | (71.1)% |
| Adjustment for income from unconsolidated affiliates, included in Aviation and Technical Solutions | (0.5) | (0.6) | 0.1 | 21.4% |
| Adjustment for tax deductions for energy efficient government buildings, included in Technical Solutions | — | (0.2) | 0.2 | NM\* |
|  | $106.0 | $109.7 | $(3.7) | (3.4)% |

\*Not meaningful

*($ in millions)*

| Business & Industry | Three Months Ended January 31, 2022 | 2021 | Increase / (Decrease) |  |
| --- | ---: | ---: | ---: | ---: |
| Revenues | $1,029.5 | $690.1 | $339.4 | 49.2% |
| Operating profit | 83.3 | 72.7 | 10.6 | 14.6% |
| Operating profit margin | 8.1% | 10.5% | (244) bps |  |

B&I revenues increased by $339.4 million, or 49.2%, during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. The increase was primarily driven by a $307.7 million revenue increase due to the Able Acquisition in the fourth quarter of 2021. In addition, as Pandemic disruptions continue to ease, revenue was positively impacted by the recovery of certain accounts, while partially offset by decrease in Pandemic-related cleaning services. Management reimbursement revenues for this segment totaled $52.5 million and $43.4 million for the three months ended January 31, 2022 and 2021, respectively.

Operating profit increased by $10.6 million, or 14.6%, during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. Operating profit margin decreased by 244 bps to 8.1% in the three months ended January 31, 2022, from 10.5% in the three months ended January 31, 2021. The decrease in operating profit margin was primarily driven by the changes in contract mix as a result of the Able Acquisition and the decrease in cleaning services for Pandemic-related demands, which have higher margins. In addition, operating profit margin was also negatively impacted by the amortization of intangibles acquired as part of the Able Acquisition.

*($ in millions)*

| Manufacturing & Distribution | Three Months Ended January 31, 2022 | 2021 | Increase / (Decrease) |  |
| --- | ---: | ---: | ---: | ---: |
| Revenues | $359.1 | $340.8 | $18.3 | 5.4% |
| Operating profit | 40.6 | 39.7 | 0.9 | 2.3% |
| Operating profit margin | 11.3% | 11.7% | (34) bps |  |

M&D revenues increased by $18.3 million, or 5.4%, during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. The increase was primarily attributable to net new business led by distribution clients, partially offset by a decrease in work orders for Pandemic-related demands.

Operating profit increased by $0.9 million, or 2.3%, during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. Operating profit margin decreased by 34 bps to 11.3% in the three months ended January 31, 2022, from 11.7% in the three months ended January 31, 2021. The decrease in operating profit margin was primarily attributable the decrease in Pandemic-related work orders, which have higher margins. The decrease in operating profit margin was partially offset by lower bad debt expense.

*($ in millions)*

| Education | Three Months Ended January 31, 2022 | 2021 | Decrease |  |
| --- | ---: | ---: | ---: | ---: |
| Revenues | $205.7 | $208.0 | $(2.3) | (1.1)% |
| Operating profit | 12.6 | 21.7 | (9.1) | (41.7)% |
| Operating profit margin | 6.1% | 10.4% | (428) bps |  |

Education revenues decreased by $2.3 million, or 1.1%, during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. The decrease was primarily attributable to the loss of certain accounts and a decrease in Pandemic-related work orders. The decrease was partially offset by recovery in the volume of our business as schools reopened to full capacity.

Operating profit decreased by $9.1 million, or 41.7%, during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. Operating profit margin decreased by 428 bps to 6.1% in the three months ended January 31, 2022, from 10.4% in the three months ended January 31, 2021. The decrease in operating margin was primarily attributable to an increase in direct labor and related costs due to the recovery in headcount as schools expanded capacity for in-person learning. Operating margin was positively impacted by a decrease in bad debt expense, reflecting strong collections and also due to higher reserves recorded in the prior year mainly associated with increasing credit risk resulting from the Pandemic, and lower amortization of intangible assets.

*($ in millions)*

| Aviation | Three Months Ended January 31, 2022 | 2021 | Increase |  |
| --- | ---: | ---: | ---: | ---: |
| Revenues | $200.3 | $140.9 | $59.4 | 42.1% |
| Operating profit | 8.9 | 3.1 | 5.8 | NM\* |
| Operating profit margin | 4.4% | 2.2% | 223 bps |  |

\*Not meaningful

Aviation revenues increased by $59.4 million, or 42.1%, during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. The increase was primarily attributable to a recovery in the volume of our U.S. and U.K. businesses due to less Pandemic-related travel restrictions and new parking-related services. Management reimbursement revenues for this segment totaled $12.3 million and $13.7 million for the three months ended January 31, 2022 and 2021, respectively.

Operating profit increased by $5.8 million during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. Operating margin increased by 223 bps to 4.4% in the three months ended January 31, 2022 from 2.2% in the three months ended January 31, 2021. The increase was primarily attributable to the recovery in the volume of our business and the strategic shift toward higher margin contracts with airports and related facilities .

*($ in millions)*

| Technical Solutions | Three Months Ended January 31, 2022 | 2021 | Increase |  |
| --- | ---: | ---: | ---: | ---: |
| Revenues | $141.8 | $112.6 | $29.2 | 25.9% |
| Operating profit | 16.9 | 6.0 | 10.9 | NM\* |
| Operating profit margin | 11.9% | 5.3% | 656 bps |  |

Technical Solutions revenues increased by $29.2 million, or 25.9%, during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. This increase was primarily driven by the growth in electric vehicle charging station installation sales. In addition, revenues was positively impacted by certain new contract wins within our U.K business.

We had an increase of operating profit of $10.9 million during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. Operating margin increased by 656 bps to 11.9% in the three months ended January 31, 2022 from 5.3% in the three months ended January 31, 2021. The increase in operating margin was primarily attributable to attributable to the $7.7 million gain recognized on the sale of a group of customer contracts related to healthcare technology management services and lower bad debt expense.

*($ in millions)*

| Corporate | Three Months Ended January 31, 2022 | 2021 | Increase |  |
| --- | ---: | ---: | ---: | ---: |
| Corporate expenses | $(55.8) | $(32.6) | $(23.2) | (71.1)% |

\*Not meaningful

Corporate expenses increased by $23.2 million during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. The increase in corporate expenses was primarily attributable to:

- a $17.1 million increase in compensation and related expenses primarily attributable to the addition of overhead related to the Able Acquisition and talent acquisition activities;
- a $11.5 million increase in certain technology projects attributable to discrete transformational costs under our **ELEVATE** strategy for developing the new enterprise resource planning system, client facing technology, workforce management tools, and data analytics; and
- an $8.3 million increase in acquisition and integration costs attributable to the Able Acquisition.

This increase was partially offset by:

- a $13.8 million decrease in insurance expense as the result of favorable self-insurance reserve adjustments from actuarial evaluations completed in the three months ended January 31, 2022, as compared to the three months ended January 31, 2021.

### Liquidity and Capital Resources

Our primary sources of liquidity are operating cash flows and borrowing capacity under our Amended Credit Facility. We assess our liquidity in terms of our ability to generate cash to fund our short- and long-term cash requirements. As such, we project our anticipated cash requirements as well as cash flows generated from operating activities to meet those needs.

In addition to normal working capital requirements, we anticipate that our short- and long-term cash requirements will include funding legal settlements, insurance claims, dividend payments, capital expenditures, share repurchases, mandatory loan repayments, and systems and technology transformation initiatives under our **ELEVATE** strategy. We anticipate long-term cash uses may also include strategic acquisitions. On a long-term basis, we will continue to rely on our Amended Credit Facility for any long-term funding not provided by operating cash flows.

We believe that our operating cash flows and borrowing capacity under our Amended Credit Facility are sufficient to fund our cash requirements for the next 12 months. In the event that our plans change or our cash requirements are greater than we anticipate, we may need to access the capital markets to finance future cash requirements. However, there can be no assurance that such financing will be available to us should we need it or, if available, that the terms will be satisfactory to us and not dilutive to existing shareholders. Additionally, since we cannot predict the duration or scope of the ongoing Pandemic, we cannot fully anticipate or reasonably estimate all the ways in which the current global health crisis and financial market conditions could adversely impact our business in fiscal year 2022.

### Credit Facility

On September 1, 2017, we refinanced and replaced our then-existing $800.0 million credit facility with a new senior, secured five-year syndicated credit facility, consisting of a $900.0 million revolver and an $800.0 million amortizing term loan, both of which were scheduled to mature on September 1, 2022. In accordance with terms of the Credit Facility, the revolver was reduced to $800.0 million on September 1, 2018.

On June 28, 2021, the Company amended and restated the Credit Facility, extending the maturity date to June 28, 2026, and increasing the capacity of the revolving credit facility from $800.0 million to $1.3 billion and the then-remaining term loan outstanding from $620.0 million to $650.0 million. The Amended Credit Facility provides for the issuance of up to $350.0 million for standby letters of credit and the issuance of up to $75.0 million in swingline advances. The obligations under the Amended Credit Facility are secured on a first-priority basis by a lien on substantially all of our assets and properties, subject to certain exceptions. Additionally, we may repay amounts borrowed under the Amended Credit Facility at any time without penalty.

Under the Amended Credit Facility, the term loan and U.S.-dollar-denominated borrowings under the revolver bear interest at a rate equal to one-month LIBOR plus a spread based upon our leverage ratio. Euro- and sterling-denominated borrowings under the revolver bear at the interest rate of the EURIBOR and SONIA reference rates, respectively, plus a spread that is based upon our leverage ratio. The spread ranges from 1.375% to 2.250% for Eurocurrency loans and 0.375% to 1.250% for base rate loans. At January 31, 2022, the weighted average interest rate on our outstanding borrowings was 1.60%. We also pay a commitment fee, based on our leverage ratio and payable quarterly in arrears, ranging from 0.20% to 0.40% on the average daily unused portion of the line of credit. For purposes of this calculation, irrevocable standby letters of credit, which are issued primarily in conjunction with our insurance programs, and cash borrowings are included as outstanding under the line of credit.

The Amended Credit Facility contains certain covenants, including a maximum total net leverage ratio of 5.00 to 1.00, a maximum secured net leverage ratio of 4.00 to 1.00, and a minimum interest coverage ratio of 1.50 to 1.00, as well as other financial and non-financial covenants. In the event of a material acquisition, as defined in the Amended Credit Facility, we may elect to increase the maximum total net leverage ratio to 5.50 to 1.00 for a total of four fiscal quarters and increase the maximum secured net leverage ratio to 4.50 to 1.00 for a total of four fiscal quarters. Our borrowing capacity is subject to, and limited by, compliance with the covenants described above. At July 31, 2021, we were in compliance with these covenants.

During the three months ended January 31, 2022, we made principal payments of $8.1 million under the term loan. At January 31, 2022, the total outstanding borrowings under our Amended Credit Facility in the form of cash borrowings and standby letters of credit were $1.0 billion and $166.9 million. At January 31, 2022, we had up to $749.3 million of borrowing capacity.

On March 5, 2021, the United Kingdom’s Financial Conduct Authority, the regulator of LIBOR, announced that the USD LIBOR rates will no longer be published after June 30, 2023. While we expect LIBOR to be available in substantially its current form until at least the end of June 30, 2023, it is possible that LIBOR will become unavailable prior to that point which may impact our Amended Credit Facility and interest rate swaps. Our current credit agreement as well as our International Swaps and Derivatives Association, Inc. agreement provide for any changes away from LIBOR to a successor rate to be based on prevailing or equivalent standards. Additionally, our interest rate swaps mature before June 30, 2023. As such, we do not anticipate a material impact related to the LIBOR transition and will continue to monitor developments related to the LIBOR transition and/or identification of an alternative, market-accepted rate.

### Reinvestment of Foreign Earnings

We plan to reinvest our foreign earnings to fund future non-U.S. growth and expansion, and we do not anticipate remitting such earnings to the United States. While U.S. federal tax expense has been recognized as a result of the Tax Cuts and Jobs Act of 2017, no deferred tax liabilities with respect to federal and state income taxes or foreign withholding taxes have been recognized.

### IFM Insurance Company

IFM Assurance Company (“IFM”) is a wholly owned captive insurance company that we formed in 2015. IFM is part of our enterprise-wide, multiyear insurance strategy that is intended to better position our risk and safety programs and provide us with increased flexibility in the end-to-end management of our insurance programs. IFM began providing coverage to us as of January 1, 2015.

### Share Repurchases

We repurchased shares under the 2019 Share Repurchase Program during the first quarter of 2022, as summarized below. These purchases may take place on the open market or otherwise, and all or part of the repurchases may be made pursuant to Rule 10b5-1 plans or in privately negotiated transactions. The timing of repurchases is at our discretion and will depend upon several factors, including market and business conditions, future cash flows, share price, share availability, and other factors at our discretion. Repurchased shares are retired and returned to an authorized but unissued status. At January 31, 2022, authorization for $131.6 million of repurchases remained under the 2019 Share Repurchase Program.

*(in millions, except per share amounts)*

|  | Three Months Ended January 31, 2022 |
| --- | ---: |
| Total number of shares purchased | 0.3 |
| Average price paid per share | $44.23 |
| Total cash paid for share repurchases | $13.3 |

### Cash Flows

In addition to revenues and operating profit, our management views operating cash flows as a good indicator of financial performance, because strong operating cash flows provide opportunities for growth both organically and through acquisitions. Operating cash flows primarily depend on: revenue levels; the quality and timing of collections of accounts receivable; the timing of payments to suppliers and other vendors; the timing and amount of income tax payments; and the timing and amount of payments on insurance claims and legal settlements.

*(in millions)*

|  | Three Months Ended January 31, 2022 | 2021 |
| --- | ---: | ---: |
| Net cash (used in) provided by operating activities | $(93.6) | $45.3 |
| Net cash used in investing activities | (12.4) | (5.2) |
| Net cash provided by (used in) financing activities | 90.3 | (57.8) |

#### Operating Activities

Net cash used in operating activities was $93.6 million during the three months ended January 31, 2022, as compared to net cash provided by operating activities of $45.3 million during the three months ended January 31, 2021. The change was primarily driven by the timing of client receivable collections, vendor payments, and the payment of deferred remittance of payroll taxes under the CARES Act.

#### Investing Activities

Net cash used in investing activities increased $7.2 million during the three months ended January 31, 2022, as compared to the three months ended January 31, 2021. This increase was primarily related to higher purchases in property, plant and equipment and investments in equity securities in the current year.

#### Financing Activities

Net cash provided by financing activities was $90.3 million during the three months ended January 31, 2022, as compared to net cash used in financing activities of $57.8 million during the three months ended January 31, 2021. The change was primarily related to an increase in net borrowings from our Amended Credit Facility in the current year.

### Contingencies

For disclosures on contingencies, see Note 10, “Commitments and Contingencies,” of the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

### Critical Accounting Policies and Estimates

Our Financial Statements are prepared in accordance with U.S. GAAP, which require us to make certain estimates in the application of our accounting policies based on the best assumptions, judgments, and opinions of our management. There have been no significant changes to our critical accounting policies and estimates. For a description of our critical accounting policies, see Item 7., “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in our Annual Report on Form 10-K for the year ended October 31, 2021.

### Recently Issued Accounting Pronouncements

| Accounting Standard Update(s) | Topic | Summary | Effective Date/ Method of Adoption |
| --- | --- | --- | --- |
| 2021-01 | Reference Rate Reform (Topic 848): Scope | This ASU, issued in January 2021, clarifies that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions under Topic 848. While we are currently evaluating the impact of implementing this guidance on our financial statements, we do not expect adoption to have a material impact. | This ASU was effective upon issuance and can be applied to hedging relationships retrospectively or prospectively through December 31, 2022. |
| 2020-04 | Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting | This ASU, issued in March 2020, provides optional expedients to assist with the discontinuance of LIBOR. The expedients allow companies to ease the potential accounting burden when modifying contracts and hedging relationships that use LIBOR as a reference rate, if certain criteria are met. While we are currently evaluating the impact of implementing this guidance on our financial statements, we do not expect adoption to have a material impact. | This ASU was effective upon issuance and can be applied prospectively to contract modifications made and hedging relationships entered into or evaluated through December 31, 2022. |

35

## Market risk

As filed, 144 characters.

There are no material changes related to market risk from the disclosures in our Annual Report on Form 10-K for the year ended October 31, 2021.

## Controls and procedures

As filed, 2,714 characters.

### a. Disclosure Controls and Procedures.

As of the end of the period covered by this report, our Principal Executive Officer and Principal Financial Officer evaluated our disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based upon that evaluation, our Principal Executive Officer and Principal Financial Officer concluded that as of the end of the period covered by this report, our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC and (2) accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, to allow timely decisions regarding required disclosure.

### b. Changes in Internal Control Over Financial Reporting.

During 2021, we completed the Able Acquisition, as described in Note 3, “Acquisitions,” to the Financial Statements in this Form 10-Q. We continue to integrate policies, processes, personnel, technology, and operations relating to this transaction and will continue to evaluate the impact of any related changes to our internal controls over financial reporting. Additionally, to support the growth of our financial shared service capabilities and standardize our financial systems, we continue to update several key platforms, including our human resources information systems, enterprise resource planning system, and labor management system. The implementation of several key platforms involves changes in the systems that include internal controls. Although some of the transitions have proceeded to date without material adverse effects, the possibility exists that they could adversely affect our internal controls over financial reporting and procedures.

There were no other changes in our internal control over financial reporting during the first quarter of 2022 identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. As a result of the Pandemic, many of our office-based employees began working remotely in March 2020. This change to the working environment did not have a material effect on our internal controls over financial reporting during the first quarter of 2022. We are continually monitoring and assessing the impact of the Pandemic and the resulting changes to our working environment on our internal controls over financial reporting.

## Risk factors

As filed, 210 characters.

There have been no material changes to the risk factors identified in our Annual Report on Form 10-K for the year ended October 31, 2021, in response to Item 1A., “Risk Factors,” of Part I of the Annual Report.

Filed Mar 9, 2022.
Source: SEC EDGAR, the filing index for accession 0000771497-22-000004. Last ingested by Listed: Nov 4, 2026, 11:52 ET. No prices; not investment advice.
